Results 31 to 40 of about 4,329,929 (348)
Peptides, Antibodies, Peptide Antibodies and More [PDF]
International Journal of Molecular Sciences, 2019 The applications of peptides and antibodies to multiple targets have emerged as powerful tools in research, diagnostics, vaccine development, and therapeutics. Antibodies are unique since they, in theory, can be directed to any desired target, which illustrates their versatile nature and broad spectrum of use as illustrated by numerous applications of ...
Nicole Trier, Paul Hansen, Gunnar Houen
openaire +3 more sources
Anti-PEG Antibodies Boosted in Humans by SARS-CoV-2 Lipid Nanoparticle mRNA Vaccine
medRxiv, 2022 Humans commonly have low level antibodies to poly(ethylene) glycol (PEG) due to environmental exposure. Lipid nanoparticle mRNA vaccines for SARS-CoV-2 contain small amounts of PEG but it is not known if PEG antibodies are enhanced by vaccination and if ...
Yi Ju +21 more
semanticscholar +1 more source
Development of antibodies for life-detection experiment in extreme environments; implications for astrobiology [PDF]
, 2010 The Life Marker Chip (LMC) instrument is an antibody assay-based system which will attempt to detect molecular signatures of Life in the Martian subsurface as part of the payload on board the European Space Agency (ESA) ExoMars mission rover, currently
Derveni, Maria Elisavet
core +3 more sources
Acknowledgement to Reviewers of Antibodies in 2019
Antibodies, 2020 The editorial team greatly appreciates the reviewers who have dedicated their considerable time andexpertise to the journal’s rigorous editorial process over the past 12 months[...]
Antibodies Editorial Office
doaj +1 more source
Neutralizing monoclonal antibodies for treatment of COVID-19
Nature reviews. Immunology, 2021 Several neutralizing monoclonal antibodies (mAbs) to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) have been developed and are now under evaluation in clinical trials.
P. Taylor +5 more
semanticscholar +1 more source
Potent neutralizing antibodies from COVID-19 patients define multiple targets of vulnerability
Science, 2020 Sites of vulnerability in SARS-CoV-2 Antibodies that neutralize severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) could be an important tool in treating coronavirus disease 2019 (COVID-19). Brouwer et al.
P. Brouwer +32 more
semanticscholar +1 more source
CODEX multiplexed tissue imaging with DNA-conjugated antibodies
Nature Protocols, 2021 Advances in multiplexed imaging technologies have drastically improved our ability to characterize healthy and diseased tissues at the single-cell level.
Sarah Black +8 more
semanticscholar +1 more source
Animal Models of IgE Anaphylaxis
Biology, 2023 Allergies and atopy have emerged as significant public health concerns, with a progressively increasing incidence over the last two decades. Anaphylaxis is the most severe form of allergic reactions, characterized by a rapid onset and potentially fatal ...
Aurélie Gouel-Chéron +3 more
doaj +1 more source
bioRxiv, 2021 Numerous antibodies that neutralize SARS-CoV-2 have been identified, and these generally target either the receptor-binding domain (RBD) or the N-terminal domain (NTD) of the viral spike.
G. Cerutti +22 more
semanticscholar +1 more source
Cell, 2020 The COVID-19 pandemic urgently needs therapeutic and prophylactic interventions. Here, we report the rapid identification of SARS-CoV-2-neutralizing antibodies by high-throughput single-cell RNA and VDJ sequencing of antigen-enriched B cells from 60 ...
Y. Cao +32 more
semanticscholar +1 more source